CDTX stock

Cidara Therapeutics Inc (CDTX) financials · rev $1.3M

Cidara Therapeutics Inc (CDTX) rev $1.3M.

Cached annual income statement
LineFY2024FY2023FY2022
Revenue$1.3M$23.3M$64.4M
Cost of Revenue$0$0$0
Gross Profit$0$0$0
Operating Income$0$0$0
Net Income-$169.8M-$22.9M-$33.6M
EPS (Diluted)$-26.75$-5.25$-0.48
Cached annual balance sheet
LineFY2024FY2023
Total Assets$214.8M$67.0M
Current Assets$0$0
Cash & Equivalents$189.8M$35.8M
Inventory$0$0
PP&E$0$0
Total Liabilities$51.5M$75.2M
Current Liabilities$0$0
Short-term Debt$0$0
Long-term Debt$0$0
Total Debt$0$0
Shareholders' Equity$0$0
Retained Earnings$0$0
Cached annual cash flow
LineFY2024FY2023FY2022
Operating Cash Flow-$176.5M-$22.4M-$28.5M
CapEx$0$0$0
Investing Cash Flow-$129.0K-$505.0K-$118.0K
Financing Cash Flow$337.1M$26.0M-$951.0K
Dividends Paid$0$0$0
Net Change in Cash$0$0$0
Free Cash Flow$0$0$0

FAQ

What is CDTX P/E and revenue?

Cidara Therapeutics Inc (CDTX) rev $1.3M.

What is CDTX revenue?

Cidara Therapeutics Inc last cached revenue is $1.3M (FY2024).

Is CDTX profitable?

Cidara Therapeutics Inc last cached net income is -$169.8M.

What are CDTX total assets?

Cidara Therapeutics Inc last cached total assets are $214.8M.

What is CDTX free cash flow?

Cidara Therapeutics Inc last cached free cash flow is $0.

Not investment advice. Cached statements, not a live tape.